Gemina Laboratories Stock Price on November 15, 2024
| GLABF Stock | USD 0.55 0.02 3.51% |
If you're considering investing in Gemina OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gemina Laboratories stands at 0.55, as last reported on the 12th of December 2024, with the highest price reaching 0.55 and the lowest price hitting 0.55 during the day. Gemina Laboratories is out of control given 3 months investment horizon. Gemina Laboratories holds Efficiency (Sharpe) Ratio of 0.16, which attests that the entity had a 0.16% return per unit of risk over the last 3 months. We have analyzed twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.13% are justified by taking the suggested risk. Use Gemina Laboratories Risk Adjusted Performance of 0.1226, downside deviation of 10.57, and Market Risk Adjusted Performance of 1.44 to evaluate company specific risk that cannot be diversified away.
Gemina OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gemina |
Sharpe Ratio = 0.1598
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GLABF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.1 actual daily | 63 63% of assets are less volatile |
Expected Return
| 1.13 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Gemina Laboratories is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gemina Laboratories by adding it to a well-diversified portfolio.
Related Headline
Acasti Pharma Headline on 25th of October 2024
Acasti Pharma changes name to Grace Therapeutics by seekingalpha.com
Acasti Pharma changes its name to Grace Therapeutics, set to trade as GRCE on Nasdaq starting October 28, 2024.
Gemina Laboratories Valuation on November 15, 2024
It is possible to determine the worth of Gemina Laboratories on a given historical date. On November 15, 2024 Gemina was worth 0.37 at the beginning of the trading date compared to the closed value of 0.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gemina Laboratories otc stock. Still, in general, we apply an absolute valuation method to find Gemina Laboratories' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gemina Laboratories where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gemina Laboratories' related companies.
| Open | High | Low | Close | Volume | |
| 0.38 | 0.38 | 0.37 | 0.37 | 5,000 | |
11/15/2024 | 0.37 | 0.37 | 0.37 | 0.37 | 1.00 |
| 0.38 | 0.38 | 0.38 | 0.38 | 25,000 |
| Backtest Gemina Laboratories | | | Gemina Laboratories History | | | Gemina Laboratories Valuation | Previous | Next |
Gemina Laboratories Trading Date Momentum on November 15, 2024
| On November 18 2024 Gemina Laboratories was traded for 0.38 at the closing time. The highest daily price throughout the period was 0.38 and the lowest price was 0.38 . The daily volume was 25 K. The net trading volume on 11/18/2024 added to the next day price rise. The overall trading delta to closing price of the next trading day was 2.70% . The overall trading delta to current closing price is 75.68% . |
Gemina Laboratories Fundamentals Correlations and Trends
By evaluating Gemina Laboratories' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gemina Laboratories' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gemina financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gemina Laboratories OTC Stock history
Gemina Laboratories investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gemina is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gemina Laboratories will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gemina Laboratories stock prices may prove useful in developing a viable investing in Gemina Laboratories
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.
Gemina Laboratories OTC Stock Technical Analysis
Gemina Laboratories technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Gemina Laboratories Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Gemina Laboratories cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gemina Laboratories December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Gemina Laboratories otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gemina Laboratories shares will generate the highest return on investment. By undertsting and applying Gemina Laboratories otc stock market strength indicators, traders can identify Gemina Laboratories entry and exit signals to maximize returns
Gemina Laboratories Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gemina Laboratories' price direction in advance. Along with the technical and fundamental analysis of Gemina OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gemina to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1226 | |||
| Jensen Alpha | 1.0 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0923 | |||
| Treynor Ratio | 1.43 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Gemina OTC Stock analysis
When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |